HIV/AIDS Clinical Trial
Official title:
Evaluation of the Short- and Mid-term Effects of an Empowerment Program Focused on Serostatus Disclosure Management for Women Living With HIV in Mali
The objective of this research is to measure the short- and mid-term effects of an empowerment program focused on serostatus disclosure management for women living with HIV (WLHIV) in Mali on the "burden of secrecy".
Serostatus disclosure is a critical issue for persons living with HIV (PLHIV). Studies
identified numerous benefits associated with disclosure, but various negative consequences
have also been documented. Gender inequality must be taken into account regarding the
disclosure issue, in particular in Mali, where women are economically dependent and have a
low decision-making power. Moreover, in Mali, since 2006, PLHIV have a legal obligation to
disclose their serostatus to their spouse and sexual partner(s) " as soon as possible, or
within 6 weeks " after the diagnosis. Although this law is not enforced, it highlights the
sensitive nature of the serostatus disclosure issue and raise concerns among PLHIV and other
stakeholders.
To support women living with HIV (WLHIV), an empowerment program (Gundo-So) was implemented
by ARCAD-SIDA in Mali, in collaboration with several partners. This program aims to empower
WLHIV, so that they can make informed decision about disclosing or keeping their serostatus
secret in their various life contexts, and that they can identify strategies to disclose or
to keep the secret, as well as to manage potential negative reactions. Gundo-So ("The room of
confidences") was adapted from a program established in quebec and has been implemented in
Mali.
The objective of this research is to measure the short- and mid-term effects of an
empowerment program focused on serostatus disclosure management for women living with HIV
(WLHIV) in Mali on the "burden of secrecy".
The evaluation of the effects of the Gundo-So program will be helpful to assess the relevance
of a national or subregional extension of the program, or even an adaptation to other target
populations (e.g. heterosexual men and men who have sex with men living with HIV).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|